To view associated reagents, ancillaries and bulks, please visit the Roche Tissue Diagnostics reagent catalog.
Be conclusive – Diagnose with CINtec® Histology
The CINtec® Histology test is the only 510(k) p16 biomarker for clinical/IVD use in the evaluation of cervical biopsy specimens.
When CINtec® Histology is used according to the LAST recommendations:
CINtec® Histology enhances identification of occult lesions that may be missed by H&E or morphologic interpretation alone.
The adjunctive use of CINtec® Histology helps pathologists ensure the right patient is treated without unnecessarily treating more patients.
The majority of pathologists using CINtec® Histology consistently identify 23% – 30% more high-grade cervical disease whether used on all biopsies or according to the LAST recommendations1.
Pathologists who use CINtec® Histology demonstrate improved diagnostic consistency and diagnostic agreement between each other and with expert gynecopathologists1.
CINtec® Histology provides objectivity to diagnostic interpretation that helps all pathologists identify more cervical disease.
19,250 CINtec® Histology slide interpretations by 70 individual surgical pathologists confirmed ≥99.1% acceptability for staining, morphology and background1.
In 100 women with disease:
CINtec® Histology finds 22.8% more high-grade disease1. These women can now be treated appropriately.